Form 8-K - Current report:
SEC Accession No. 0000886163-15-000040
Filing Date
2015-04-23
Accepted
2015-04-23 16:06:29
Documents
3
Period of Report
2015-04-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lgnd_form8-krehermanxdesil.htm 8-K 26019
2 EXHIBIT 99.1 melaniehermannamedinterim-.htm EX-99.1 11253
3 melaniehermannamedint_image1.gif GRAPHIC 11576
  Complete submission text file 0000886163-15-000040.txt   54637
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 15788511
SIC: 2834 Pharmaceutical Preparations